Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease acute myocardial infarction
Phenotype C0011849|diabetes mellitus
Sentences 8
PubMedID- 23226370 Although clinical outcomes of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus (t2dm) is well established to be worse than non-diabetic patients [1], [2], the reasons for this remain unclear.
PubMedID- 21393298 Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure.
PubMedID- 26279482 Aims: to assess the risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus treated with long-acting insulin analogues in comparison with other basal insulin therapy.
PubMedID- 24843443 Furthermore, anemia is accompanied by cardiovascular events9–12, mortality13 and mortality after acute myocardial infarction16 in patients with diabetes mellitus.
PubMedID- 24399329 Risk of ischemic stroke after an acute myocardial infarction in patients with diabetes mellitus.
PubMedID- 20484611 Recent meta-analyses suggest an increased risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus (t2dm) treated with rosiglitazone.
PubMedID- 24529823 Glycemic variability predicts cardiovascular complications in acute myocardial infarction patients with type 2 diabetes mellitus.
PubMedID- 26209521 Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus.

Page: 1